論文 - 藤田 尚紀
-
Associations of impaired grip strength and gait function with the severity of erectile dysfunction in men undergoing dialysis: a cross-sectional study
Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama
The Aging Male 2021年12月
-
Management of bladder cancer in older patients
Shingo Hatakeyama, Shintaro Narita, Kazutaka Okita, Takuma Narita, Hiromichi Iwamura, Naoki Fujita, Junichi Inokuchi, Yoshiyuki Matsui, Hiroshi Kitamura, Chikara Ohyama
Japanese journal of clinical oncology 2021年12月
-
The cell surface hyaluronidase TMEM2 is essential for systemic hyaluronan catabolism and turnover
Yuki Tobisawa, Naoki Fujita, Hayato Yamamoto, Chikara Ohyama, Fumitoshi Irie, Yu Yamaguchi
The Journal of biological chemistry 2021年11月
-
Oncologic and patient-reported outcomes after robot-assisted radical prostatectomy in men aged ≥75 years
Kyo Togashi, Shingo Hatakeyama, Teppei Okamoto, Yuta Kojima, Hiromichi Iwamura, Naoki Fujita, Takuma Narita, Itsuto Hamano, Tomoko Hamaya, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
Urologic oncology 2021年10月
-
The impact of eligibility for maintenance immunotherapy on prognosis in patients with unresectable or metastatic urothelial carcinoma
Kai Ozaki, Shingo Hatakeyama, Toshikazu Tanaka, Daisuke Noro, Noriko Tokui, Hirotaka Horiguchi, Yoshiharu Okuyama, Naoki Fujita, Teppei Okamoto, Akiko Okamoto, Yuichiro Suzuki, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
BJUI Compass 2021年08月
-
Prognostic impact of eligibility for adjuvant immunotherapy in locally advanced urothelial cancer
Yuki Miura, Shingo Hatakeyama, Toshikazu Tanaka, Naoki Fujita, Hirotaka Horiguchi, Yoshiharu Okuyama, Yuta Kojima, Daisuke Noro, Noriko Tokui, Teppei Okamoto, Hayato Yamamoto, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
BJUI Compass 2021年08月
-
The effect of number of treatment cycles of platinum-based first-line chemotherapy on maximum radiological response in patients with advanced urothelial carcinoma
Okita K, Hatakeyama S, Hagiwara K, Suzuki Y, Tanaka T, Noro D, Tokui N, Fujita N, Konishi S, Okamoto T, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C
2021年04月
-
Prognostic significance of the Ki67 index and programmed death-ligand 1 expression after radical cystectomy in patients with muscle-invasive bladder cancer
Horiguchi H, Hatakeyama S, Yoneyama T, Yoneyama MS, Tanaka T, Fujita N, Okamoto T, Yamamoto H, Yoneyama T, Yoshizawa T, Hashimoto Y, Kawaguchi T, Ohyama C
39 ( 4 ) 238.e9 - 238.e17 2021年04月
-
Effect of frailty and comorbidity on surgical contraindication in patients with localized prostate cancer (FRART-PC Study)
Kodama H, Hatakeyama S, Momota M, Togashi K, Hamaya T, Hamano I, Fujita N, Kojima Y, Okamoto T, Yoneyama T, Yamamoto H, Yoshikawa K, Yoneyama T, Hashimoto Y, Ohyama C
39 ( 3 ) 191.e1 - 191.e8 2021年03月
-
Impact of chronic kidney disease on oncological outcomes in patients with high-risk non-muscle-invasive bladder cancer who underwent adjuvant bacillus Calmette-Guérin therapy
Fujita N, Hatakeyama S, Okita K, Momota M, Narita T, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C
39 ( 3 ) 191.e9 - 191.e16 2021年03月
-
Impact of symptomatic recurrence on oncological outcomes in patients with primary high-risk non-muscle-invasive bladder cancer
Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C
39 ( 3 ) 194.e9 - 194.e16 2021年03月
-
Relationship of frailty with treatment modality selection in patients with muscle-invasive bladder cancer (FRART-BC study)
Iwamura H, Hatakeyama S, Momota M, Kojima Y, Narita T, Okamoto T, Fujita N, Hamano I, Togashi K, Hamaya T, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C
Translational andrology and urology 10 ( 3 ) 1143 - 1151 2021年03月
-
The effect of frailty on the quality of life and lower urinary symptoms following robot-assisted radical prostatectomy: A longitudinal analysis (FRARP-QL Study)
Togashi K, Hatakeyama S, Kojima Y, Momota M, Narita T, Iwamura H, Hamano I, Hamaya T, Fujita N, Okamoto T, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C
39 ( 3 ) 192.e7 - 192.e14 2021年03月
-
Trends in the use of neoadjuvant chemotherapy and oncological outcomes for high-risk upper tract urothelial carcinoma: a multicentre retrospective study
Hamaya T, Hatakeyama S, Tanaka T, Kubota Y, Togashi K, Hosogoe S, Fujita N, Kusaka A, Tokui N, Okamoto T, Yamamoto H, Yoneyama T, Yoneyama T, Hashimoto Y, Ohyama C
2021年01月
-
Intraoperative upper urinary tract cytology examination is a risk factor of upper urinary tract recurrence in patients with non-muscle-invasive bladder cancer
Fujita N, Hatakeyama S, Okita K, Momota M, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C
39 ( 1 ) 75.e9 - 75.e16 2021年01月
-
Association between the baseline frailty and quality of life in patients with prostate cancer (FRAQ-PC study)
Hamaya T, Hatakeyama S, Momota M, Narita T, Iwamura H, Kojima Y, Hamano I, Fujita N, Okamoto T, Togashi K, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C
26 ( 1 ) 199 - 206 2021年01月
-
Safety and Feasibility of Radiation Therapy to the Primary Tumor in Patients With Metastatic Castration-resistant Prostate Cancer
Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Mariya Y, Ohyama C
18 ( 5 ) e523 - e530 2020年10月
-
Impact of substratification on predicting oncological outcomes in patients with primary high-risk non-muscle-invasive bladder cancer who underwent transurethral resection of bladder tumor
Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C
38 ( 10 ) 795.e9 - 795.e17 2020年10月
-
Safety and efficacy of intensive instillation of low-dose pirarubicin vs. bacillus Calmette-Guérin in patients with high-risk non-muscle-invasive bladder cancer
Fujita N, Hatakeyama S, Momota M, Kido K, Narita T, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C
38 ( 8 ) 684.e17 - 684.e24 2020年08月
-
Frailty is significantly associated with the type of urinary diversion in patients with muscle-invasive bladder cancer
Okita K, Hatakeyama S, Momota M, Soma O, Hamano I, Tanaka T, Iwamura H, Fujita N, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Kawaguchi T, Ohyama C
International journal of urology 27 ( 8 ) 649 - 654 2020年08月